US EPA

In December 2016, EPA finalized its Evaluation of the Inhalation Carcinogenicity of Ethylene Oxide. EPA’s evaluation was reviewed internally by EPA and by other federal agencies and White House Offices in October 2016, before public release. Consistent with the May 2009 IRIS assessment development process, all written comments on IRIS assessments submitted by other federal agencies and White House Offices are made publicly available. Accordingly, interagency comments and the interagency science discussion materials provided to other agencies, including interagency review drafts of the EPA’s Evaluation of the Inhalation Carcinogenicity of Ethylene Oxide, are posted on this site.

Note: No major science comments were received on the Interagency Science Discussion Draft.

Ethylene oxide (EtO) is a gas at room temperature. It is manufactured from ethylene and is a chemical intermediate in the manufacturing of various chemicals. It is also used as a sterilizing agent for medical and dental equipment and as a fumigating agent for spices and certain other items. The highest levels of human exposure are in occupations involving contact with the gas in plants that manufacture or use EtO and in hospitals that sterilize medical equipment. EtO can also be inhaled by residents living near facilities that produce or use EtO or near sterilizing/fumigating facilities.

The DNA-damaging properties of EtO have been studied since the 1940s. EtO is known to be mutagenic in a large number of living organisms, ranging from bacteriophage to mammals, and it also induces chromosome damage. It is carcinogenic in mice and rats, inducing tumors of the lymphohematopoietic system, brain, lung, connective tissue, uterus, and mammary gland. In humans employed in EtO-manufacturing facilities and in sterilizing facilities, there is strong evidence of an increased risk of cancer of the lymphohematopoietic system and of breast cancer in females.

The Toxicological Review and charge were reviewed internally by EPA and by other federal agencies and White House Offices before public release. Consistent with the May 2009 IRIS assessment development process, all written comments on IRIS assessments submitted by other federal agencies and White House Offices are made publicly available. Accordingly, interagency comments and the interagency science consultation materials provided to other agencies, including interagency review drafts of the IRIS Toxicological Review of Ammonia and the charge to external peer reviewers, are posted on this site.

Following review by SAB and consideration of public comments received, the Agency revised the draft assessment and sent it back to Final Agency review and Interagency Science Discussion (step 6 of the IRIS process). Once this was done, the carcinogenicity assessment was finalized (step 7 of the IRIS process) and placed in the IRIS database.

U.S. EPA. Evaluation of the Inhalation Carcinogenicity of Ethylene Oxide (2016 Interagency Science Discussion Draft). U.S. Environmental Protection Agency, Washington, DC, EPA/635/R-16/284a-b, 2016.